The beat-and-raise quarter with improving margins and strong Cigna Healthcare performance supports a bullish read-through. Monitor the Pharmacy Benefit Services margin trajectory and the impact of expected client transitions on Evernorth's profitability. The raised guidance (+$0.10) is modest but signals confidence in the diversified portfolio.
Price Chart
Executive Summary
Cigna Group reported strong Q1 2026 results with adjusted EPS of $7.79, beating the $7.62 consensus by 2.2%, and total revenue of $68.5B (+5% YoY). The company raised its full-year 2026 adjusted EPS outlook to at least $30.35 (from at least $30.25), driven by strong performance in Cigna Healthcare (pre-tax income +18% YoY) and improved operating efficiency, partially offset by a 28% decline in Pharmacy Benefit Services operating income.
Key Financial Metrics
Key Facts
- Q1 2026 adjusted EPS $7.79 vs consensus $7.62 (beat by 2.2%)
- Q1 2026 total revenue $68.5B, +5% YoY
- Full-year 2026 adjusted EPS guidance raised to at least $30.35 (from at least $30.25)
- Cigna Healthcare pre-tax adjusted income +18% YoY to $1.514B
- Cigna Healthcare MCR improved to 79.8% from 82.2% YoY
- Evernorth Health Services adjusted revenue +9% YoY, but pre-tax income only +2%
- Pharmacy Benefit Services pre-tax income -28% YoY due to lower contributions from large clients
- SG&A expense ratio improved to 5.4% from 6.4% YoY (adjusted 4.8% from 5.8%)
- Debt-to-capitalization ratio improved to 42.3% from 43.0% at year-end 2025
- Total medical customers increased 1% from Dec 2025 to 18.3M
Financial Impact
Q1 2026 adjusted EPS $7.79 vs $7.62 consensus; revenue $68.5B vs $66.2B consensus; guidance raised by $0.10 to at least $30.35
Risk Factors
- Pharmacy Benefit Services pre-tax income declined 28% YoY, indicating competitive pressure in PBM
- Total pharmacy customers decreased 2% from Dec 2025, reflecting expected client transitions
- Cigna Healthcare adjusted revenue declined 21% YoY (though +8% ex-HCSC divestiture)
- Full-year guidance raise of only $0.10 suggests limited upside conviction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-017971 |
| Document: ef20071317_8k.htm | 0001140361-26-017971 |
| Document: 0001140361-26-017971-index-headers.html | 0001140361-26-017971 |
| Document: 0001140361-26-017971-index.html | 0001140361-26-017971 |
| Document: 0001140361-26-017971.txt | 0001140361-26-017971 |
| 8-K Data (Synthetic) | 0001140361-26-017971 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 28d ago | 144 | $286.26 $280.76 | ▼ −1.92% | ▼ −0.77% | $267.67 (−6.49%) |
Aug 18, 2026 6w ago | 144 | $278.50 $279.32 | ▲ +0.29% | ▲ +0.50% | $267.67 (−3.89%) |
Aug 4, 2026 8w ago | 144 | $273.45 $273.87 | ▲ +0.16% | ▲ +0.25% | $267.67 (−2.11%) |
Jul 9, 2026 12w ago | 3 | $293.46 $283.82 | ▼ −3.28% | ▼ −2.72% | $267.67 (−8.79%) |
May 13, 2026 20w ago | 8-K | $300.42 $291.28 | ▼ −3.04% | ▼ −1.88% | $267.67 (−10.90%) |
May 6, 2026 21w ago | Court Ruling | $281.98 $300.71 | ▲ +6.64% | ▲ +5.49% | $267.67 (−5.07%) |
Apr 30, 2026 22w ago | 8-K | $290.33 $283.65 | ▼ −2.30% | ▼ −4.03% | $267.67 (−7.80%) |
Apr 24, 2026 23w ago | Court Ruling | $275.24 $290.58 | ▲ +5.57% | ▲ +4.67% | $267.67 (−2.75%) |
Mar 13, 2026 28w ago | DEFA14A | $268.31 $261.49 | ▼ −2.54% | ▼ −0.50% | $267.67 (−0.24%) |
Feb 27, 2026 31w ago | 8-K | $289.40 $271.04 | ▼ −6.34% | ▼ −4.36% | $267.67 (−7.51%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access